Brief: Evotec Announces Progress In Protein Degradation Collaboration With Bristol Myers Squibb
April 24 (Reuters) - Evotec SE EVTG.DE: EQS-NEWS: EVOTEC ANNOUNCES SIGNIFICANT PROGRESS IN STRATEGIC PROTEIN DEGRADATION COLLABORATION WITH BRISTOL MYERS SQUIBB EVOTEC SE - TO RECEIVE $75 MILLION IN PAYMENTS EVOTEC SE - COLLABORATION AIMS TO IDENTIFY NOVEL MOLECULAR GLUE DEGRADERS Source text: ID:nEQ7PJVmja Further company coverage: EVTG.DE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases